# Codex Final EXIT — v1.10.1 Hygiene Cycle (parallel scoped reviews)

**Cycle:** v1.10.1 hygiene cycle (physical merge of v1.10 PRD Update Cycle delta artifacts into bundle file bodies)
**Authorization:** Evans's "use your recommended and go yolo mode" 2026-05-02; "i agree" to multi-agent orchestration adoption + parallel scoped Codex review pattern.
**Workstream lead:** Evans (Product Lead, via Claude proxy as orchestrator)
**Adversarial reviewer:** Codex (gpt-5.5)

## Cycle scope (now physically merged into bundle bodies)

- **Phase A** (6 Contracts Pack core): INVARIANTS v5.2, AUDIT_EVENTS v5.2, CCR_RUNTIME v5.2, TYPES v5.2, GLOSSARY v5.2, AI_LAYERING v5.2.
- **Phase B** (4 Contracts Pack remainder): DOMAIN_EVENTS v5.2, FORMS_ENGINE v5.2, GOVERNANCE_CONTROLS v5.2, MARKET_LAUNCH v5.1.
- **Phase C** (6 engineering specs): CDM v1.2, State Machines v1.1, OpenAPI v0.2, RBAC v1.1, System Architecture v1.2, Tenant Threading Addendum v1.0 — additive "v1.10 cycle additions" sections in each.
- **Phase D** (slice PRDs + OR Tracker + DIC + other docs + country regulatory placeholders): ~26 files via 6 parallel sub-agents.

Each file: pointer-note headers (where present from v1.10 promotion) removed; substantive v1.10 content folded into the body; v5.2/v1.10-cycle doc-control entries added.

## Source delta artifacts (authoritative reference; NOT modified)

- `Telecheck_v1_10_PRD_Update/Phase3_INVARIANTS_v1_10_Edits_2026-05-01.md`
- `Telecheck_v1_10_PRD_Update/Phase3_AUDIT_EVENTS_v1_10_Edits_2026-05-01.md`
- `Telecheck_v1_10_PRD_Update/Phase3_Group2_Contracts_v1_10_Edits_2026-05-01.md`
- `Telecheck_v1_10_PRD_Update/Phase3_Group3_Contracts_v1_10_Edits_2026-05-01.md`
- `Telecheck_v1_10_PRD_Update/Phase2_F13_Glossary_Reconciled_2026-05-01.md`
- `Telecheck_v1_10_PRD_Update/Phase5_Slice_Engineering_Operations_Delta_2026-05-01.md`

## Parallel scoped reviews

Per Evans's authorization to fan out adversarial review by domain, you are running **4 parallel scoped reviews**:

### Scope 1 — Clinical safety
Focus: I-012 reject-unless three-clause rule (string equality `autonomy_level == action_with_confirm`; audit-chain confirmation event; RBAC role); I-019 crisis detection invariant; ADR-005 protocolized autonomy preservation; ADR-002 binary AI mode preservation; AI workload taxonomy supersession scope (active vs reserved workload types and autonomy levels); §13.7 single normative source of truth discipline; State Machines `ProtocolAuthorizedAction` reserved transitions documented as non-normative future sketches (NOT executable code paths at v1.0).

Files in scope: AI_LAYERING v5.2 §10; AUDIT_EVENTS v5.2 §3 (I-012 audit-side rule); STATE_MACHINES v1.1 v1.10 cycle additions §ProtocolAuthorizedAction; AI Clinical Assistant Slice §3 + §13 (Phase D5).

Question to answer: any I-012 / autonomy-level / reserved-transition relaxation? Any drift between Master PRD §13.7 and the contract mirrors?

### Scope 2 — Privacy
Focus: I-029 research data export gates (DSA active + active research consent + k-anonymity ≥ k_min); I-030 consent-zero-impact on care delivery (Forms Engine 6-category static analysis); I-031 high_pii audit class for research export events; failed-export audit-path discipline (`research.export_completed` with `status = invalidated` paired with `signal_enforcement_trigger` Category B; bare suppression forbidden per I-003); 5th consent tier asymmetric retraction acknowledgment.

Files in scope: INVARIANTS v5.2 §I-029, §I-030, §I-031; AUDIT_EVENTS v5.2 §5 research events; CCR_RUNTIME v5.2 research block; TYPES v5.2 ResearchDataExport; FORMS_ENGINE v5.2 research consent integration; GOVERNANCE_CONTROLS v5.2 §7; STATE_MACHINES v1.1 v1.10 cycle additions §research; CDM v1.2 v1.10 cycle additions §research entities; OpenAPI v0.2 v1.10 cycle additions §research endpoints; RBAC v1.1 v1.10 cycle additions §research roles; System Architecture v1.2 v1.10 cycle additions §Research Data Export Module; Phase D4 slice edits.

Question to answer: any privacy invariant relaxation? Any care-delivery surface that branches on research consent (I-030 violation)? Any export pathway that emits without high_pii (I-031 violation)? Any place where bare suppression of failed exports is permitted (I-003 violation)?

### Scope 3 — Regulatory
Focus: ADR-027 country-conditional DTC marketing posture activation gate (Tier-2 regulatory evidence; triple sign-off + Country Launch Director; CCR `marketing_copy_governance_evidence` structured-object completeness rejection rule); ADR-028 research data partnership Posture A activation gate (11 conditions including REC concurrence, quad sign-off, closed-enum `research_permitted_data_domains` country gate, DSA permitted-domain subset check, k_min hierarchy); CCR initial values per launch country (US `prohibited` permanent + `consent_only`; GH `pending_evidence` + `consent_only`); cross-border transfer evidence companion structured object.

Files in scope: ADR-027, ADR-028 (in bundle); CCR_RUNTIME v5.2 marketing + research blocks + Initial values per launch country table; MARKET_LAUNCH v5.1 marketing posture activation gate + research data partnership activation gate; TYPES v5.2 MarketingCopyGovernanceEvidence + DataSharingAgreement; Phase D3 + D4 slice edits; Phase D6 country-regulatory placeholder files.

Question to answer: any activation-gate condition missing or weakened? Any place where the `pending_evidence` / `consent_only` initial states are bypassed? Any DSA scope that exceeds country-level `research_permitted_data_domains`? Any cross-border transfer evidence missing required fields when CCR enum requires them?

### Scope 4 — Brand structure (C3) consistency
Focus: operating tenant naming `Telecheck-{country}`; consumer DBA `Heros Health` country-instanced via subdomains; bare `Heros` forbidden as tenant identifier; §17 contextual carve-outs; `chatbot` universally forbidden; `Mode 1` / `Mode 2` ↔ `conversational_assistant` / `protocol_execution` mapping consistent with code-vs-UI rule.

Files in scope: GLOSSARY v5.2 §Brand and tenant terms + amended `tenant` entry + Forbidden-alias updates + new anti-patterns; CDM v1.2 v1.10 cycle additions §Tenant entity; RBAC v1.1 v1.10 cycle additions §Tenant scoping examples; OpenAPI v0.2 v1.10 cycle additions §Tenant identifier convention; Tenant Threading Addendum v1.0 v1.10 cycle additions §Tenant ID examples sweep; System Architecture v1.2 v1.10 cycle additions §Cross-border posture refresh; Phase D2 + D6 slice/control-plane edits.

Question to answer: any surviving bare `Heros` references (without `Health` qualifier or DBA framing) outside the §17 carve-outs? Any operating-tenant naming that doesn't follow `Telecheck-{country}`? Any patient-facing surface sourced from `tenant.id` instead of `tenant.consumer_dba`? Any `chatbot` references? Any code-vs-UI rule violation (code/schema/audit using "Mode 1" / "Mode 2" instead of taxonomy values)?

## Findings format per scope

Standard HIGH / MEDIUM / LOW. For each finding: file, line range or section, problem, recommended fix.

If 0 HIGH / 0 MEDIUM across all 4 scopes, the v1.10.1 hygiene cycle exits successfully and the bundle is the new canonical baseline. The 4 reports compose into a single EXIT verification.

## Out of scope

- Source delta artifacts in `Telecheck_v1_10_PRD_Update/` (these are reference inputs; not modified).
- The v1.10 promotion baseline itself (this hygiene cycle layers on top of v1.10).
- Workstream-discipline note `Telecheck_Workstream_Discipline_Note_Multi_Agent_Orchestration_v0_1_DRAFT.md` (separate review when graduating to ADR-035 if pilot succeeds).
